e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer
Date
2014
Authors
Heiniger, L.
Butow, P.
Olver, I.
Grimison, P.
Ben Smith, A.
Klein, B.
Wootten, A.
Abbott, J.-A.
Price, M.
McJannett, M.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Conference item
Citation
Asia Pacific Journal of Clinical Oncology, 2014, vol.10, iss.Suppl. 8, pp.102-102
Statement of Responsibility
L. Heiniger, P. Butow, I. Olver, P. Grimison, A. B. Smith, B.Klein, A. Wootten, J. Abbott, M. Price, M. McJannett, B. Tran, M. Stockler, H. Gurney
Conference Name
Annual Scientific Meeting, from ideas to outcomes: Patient focused research (ANZUP) (13 Jul 2014 - 15 Jul 2014 : Melbourne, Vic.)
Abstract
Objective: Currently all women who have completed their primary treatment for early breast cancer are invited to receive routine annual mammography. There is no randomised controlled trial evidence to support this schedule, and model-based analysis is required. This paper describes a novel data collection and model calibration process to analyse the costeffectiveness of alternative follow-up schedules for early breast cancer survivors. Methods: A discrete event simulation model describes the progression of early breast cancer after completion of primary treatment, representing impalpable and palpable recurrence and the detection of impalpable disease via follow-up mammography. Retrospective data from the South Australian cancer registry, and clinical and administrative hospital databases were linked for 407 postmenopausal women diagnosed with moderate prognosis early breast cancer from 2000-2008. These data formed the basis of a patient-level probabilistic calibration process. Results: For 50-69 year old survivors, annual follow-up for 5 years, with 2 yearly visits thereafter appears to be cost-effective. For women aged 70-79 years at diagnosis, a surveillance schedule similar to general population screening (2 yearly) appears to be most cost-effective if high rates of adherence can be maintained. Conclusions: This study had demonstrated the potential value of combining linked, retrospective data and decision analytic modelling to provide estimates of costs and health outcomes that are sufficiently robust to inform cancer clinical guidelines and individual patient decisions regarding appropriate follow-up schedules
School/Discipline
Dissertation Note
Provenance
Description
Oral Abstract #88
Access Status
Rights
© 2014 The Authors. Asia-Pacific Journal of Clinical Oncology © 2014 Wiley Publishing Asia Pty Ltd